Optimizing paediatric specialist referrals for short stature in an era of multiple growth hormone indications

Preetha Krishnamoorthy1, Nancy Gagné2, Rose Girgis3

  • 1Division of Endocrinology and Metabolism, Department of Pediatrics, McGill University Health Center, Montreal, Quebec, Canada.

Paediatrics & Child Health
|September 16, 2024
PubMed

Insights

Timely assessment of atypical growth in children is crucial for early intervention in growth disorders. This study developed Canadian guidelines and referral tools to improve care for children with growth issues.

Area of Science:

  • Pediatric Medicine
  • Endocrinology
  • Child Health

Background:

  • Atypical growth in children can indicate underlying health conditions requiring timely treatment.
  • Morbidity associated with growth disorders necessitates prompt intervention.
  • Canada lacks specific guidelines for referring children with short stature, unlike Europe and the USA.

Purpose of the Study:

  • To develop consensus-based recommendations for assessing atypical growth in Canadian children.
  • To identify red flags for early referral of children with potential growth disorders.
  • To create a referral algorithm and form for primary care providers to ensure timely and appropriate referrals.

Main Methods:

  • Consultations and workshops involving pediatricians, pediatric endocrinologists, family physicians, and nurses.
  • Development of a consensus-based set of recommendations.
  • Creation of a referral algorithm and standardized referral form.

Main Results:

  • A consensus was reached on recommendations for evaluating atypical growth in children.
  • Key red flags were identified to guide early referrals.
  • A practical referral algorithm and form were developed for primary care.

Conclusions:

  • The developed recommendations and tools aim to standardize and improve the referral process for children with growth disorders in Canada.
  • Early identification and referral are essential for managing pediatric growth conditions effectively.
  • These resources will support primary care providers in making timely and informed decisions for children with atypical growth.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.4K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
279
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
65.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
157
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K